Nutrition in Idiopathic Pulmonary Fibrosis: Multidisciplinary Work as an Approach to the Future

Main Article Content

Juan Enghelmayer
Verónica Inés Barcos
https://orcid.org/0000-0003-1488-8437

Abstract

Idiopathic pulmonary fibrosis (IPF) is the most common interstitial pneumonia and has undergone significant diagnostic and therapeutic advances in recent years. However, little has been investigated so far regarding the nutritional alterations associated with the disease. The prevalence of malnutrition associated with IPF has been estimated around 30%, but it can reach up to 60% in patients awaiting lung transplantation. Malnutrition is an independent predictor of mortality in patients with IPF, and often manifests through weight reduction and/or changes in body composition, which can lead to a deterioration in muscle and/or bone mass. The origin of malnutrition in IPF is multifactorial and not entirely known. Some patients with advanced IPF, even having a preserved body weight, tend to have a loss of lean mass, which is associated with muscle dysfunction and poor physical performance. The resulting muscle weakness leads to physical deconditioning and greater dyspnea, reduced exercise tolerance and deterioration in quality of life. Consequently, in order to improve the approach to IPF, the nutritionist should be incorporated into the multidisciplinary team with the aim of making an early diagnosis of nutritional status, which will allow the identification of early alterations and the appropriate nutritional intervention.

Downloads

Download data is not yet available.

Article Details

How to Cite
Enghelmayer, J., & Barcos, V. I. (2022). Nutrition in Idiopathic Pulmonary Fibrosis: Multidisciplinary Work as an Approach to the Future. Respirar, 14(4), 222–227. https://doi.org/10.55720/respirar.14.4.7
Section
Revisiones

References

Raghu G, Remy-Jardin M, Richeldi L et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2022;205(9):e18–47. http://dx.doi.org/10.1164/rccm.202202-0399ST

Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res 2018;19(1):32. http://dx.doi.org/10.1186/s12931-018-0730-2

Man L, Hong P. Idiopathic Pulmonary Fibrosis: A Systemic Disease? Chin Med J 2017;130(17):2140–1. http://dx.doi.org/10.4103/0366-6999.213423

Nordén J, Grönberg AM, Bosaeus I et al. Nutrition impact symptoms and body composition in patients with COPD. Eur J Clin Nutr 2015;69(2):256–61. http://dx.doi.org/10.1038/ejcn.2014.76

Cederholm T, Barazzoni R, Austin P et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 2017;36(1):49–64. http://dx.doi.org/10.1016/j.clnu.2016.09.004

Jouneau S, Kerjouan M, Rousseau C et al. What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center. Nutrition 2019;62:115–21. http://dx.doi.org/10.1016/j.nut.2018.12.008

Schols AMWJ, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82(1):53–9. http://dx.doi.org/10.1093/ajcn.82.1.53

Vestbo J, Prescott E, Almdal T et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173(1):79–83. http://dx.doi.org/10.1164/rccm.200506-969OC

Alakhras M, Decker PA, Nadrous HF, Collazo-Clavell M, Ryu JH. Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Chest 2007;131(5):1448–53. http://dx.doi.org/10.1378/chest.06-2784

Kishaba T, Nagano H, Nei Y, Yamashiro S. Body mass index-percent forced vital capacity-respiratory hospitalization: new staging for idiopathic pulmonary fibrosis patients. J Thorac Dis 2016;8(12):3596–604. http://dx.doi.org/10.21037/jtd.2016.12.49

Nishiyama O, Yamazaki R, Sano H et al. Fat-free mass index predicts survival in patients with idiopathic pulmonary fibrosis. Respirology 2017;22(3):480–5. http://dx.doi.org/10.1111/resp.12941

Thibault R, Le Gallic E, Picard-Kossovsky M, Darmaun D, Chambellan A. Assessment of nutritional status and body composition in patients with COPD: comparison of several methods. Rev Mal Respir 2010;27(7):693–702. http://dx.doi.org/10.1016/j.rmr.2010.06.013

Almeida JMG, García CG, Castañeda VB, Guerrero DB. Nuevo enfoque de la nutrición. Valoración del estado nutricional del paciente: función y composición corporal. Nutrición Hospitalaria 2018;35:3. http://dx.doi.org/10.20960/nh.2027

Gea J, Badenes D, Balcells E. Nutritional status in patients with Idiopathic Pulmonary Fibrosis. Pulm Crit Care Med 2018;3(1). http://dx.doi.org/10.15761/pccm.1000147

Kyle UG, Bosaeus I, De Lorenzo AD et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23(6):1430–53. http://dx.doi.org/10.1016/j.clnu.2004.09.012

Thibault R, Genton L, Pichard C. Body composition: why, when and for who? Clin Nutr 2012;31(4):435–47. http://dx.doi.org/10.1016/j.clnu.2011.12.011

Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest 1996;109(3):741–9. http://dx.doi.org/10.1378/chest.109.3.741

Faverio P, Fumagalli A, Conti S et al. Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study. ERJ Open Res 2022;8(1). http://dx.doi.org/10.1183/23120541.00443-2021

Schwebel C, Pin I, Barnoud D et al. Prevalence and consequences of nutritional depletion in lung transplant candidates. Eur Respir J 2000;16(6):1050–5. http://dx.doi.org/10.1034/j.1399-3003.2000.16f05.x

Nakatsuka Y, Handa T, Kokosi M et al. The Clinical Significance of Body Weight Loss in Idiopathic Pulmonary Fibrosis Patients. Respiration 2018;96(4):338–47. http://dx.doi.org/10.1159/000490355

Jouneau S, Crestani B, Thibault R et al. Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss. Respiration 2022;101(2):142–54. http://dx.doi.org/10.1159/000518855

Gea J, Sancho-Muñoz A, Chalela R. Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations. J Thorac Dis 2018;10(Suppl 12):S1332–54. http://dx.doi.org/10.21037/jtd.2018.02.66

Cruz-Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48(1):16–31. http://dx.doi.org/10.1093/ageing/afy169

Gea J, Bàdenes D, Balcells E. Nutritional Abnormalities And Muscle Dysfunction In Idiopathic Pulmonary Fibrosis. Arch Bronconeumol 2018;54(11):545–6. http://dx.doi.org/10.1016/j.arbres.2018.04.008

Madill J, Maurer JR, de Hoyos A. A comparison of preoperative and postoperative nutritional states of lung transplant recipients. Transplantation 1993;56(2):347–50. http://dx.doi.org/10.1097/00007890-199308000-00018

Jalaber C, Lemerre-Poincloux J, Jouneau S et al. Usefulness of Body Composition CT Analysis in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study. Acad Radiol 2022;29 Suppl 2:S191–201. http://dx.doi.org/10.1016/j.acra.2021.07.020

Kozu R, Jenkins S, Senjyu H. Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to Medical Research Council dyspnea grade. Arch Phys Med Rehabil 2014;95(5):950–5. http://dx.doi.org/10.1016/j.apmr.2014.01.016

Jackson RM, Gómez-Marín OW, Ramos CF et al. Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation. Lung 2014;192(3):367–76. http://dx.doi.org/10.1007/s00408-014-9566-9

Nishiyama O, Taniguchi H, Kondoh Y et al. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest 2005;127(6):2028–33. http://dx.doi.org/10.1378/chest.127.6.2028

van Manen MJG, Geelhoed JJM, Tak NC, Wijsenbeek MS. Optimizing quality of life in patients with idiopathic pulmonary fibrosis. Ther Adv Respir Dis 2017;11(3):157–69. http://dx.doi.org/10.1177/1753465816686743

Kanjrawi AA, Mathers L, Webster S, Corte TJ, Carey S. Nutritional status and quality of life in interstitial lung disease: a prospective cohort study. BMC Pulm Med 2021;21(1):51. http://dx.doi.org/10.1186/s12890-021-01418-5

Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol 2015;22:100–6. http://dx.doi.org/10.1016/j.coph.2015.04.003

Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996;76(3):839–85. http://dx.doi.org/10.1152/physrev.1996.76.3.839

Argilés JM, Busquets S, Felipe A, López-Soriano FJ. Muscle wasting in cancer and ageing: cachexia versus sarcopenia. Adv Gerontol 2006;18:39–54.

Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366(21):1968–77. http://dx.doi.org/10.1056/NEJMoa1113354

Hasselgren PO, Alamdari N, Aversa Z, Gonnella P, Smith IJ, Tizio S. Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation. Curr Opin Clin Nutr Metab Care 2010;13(4):423–8. http://dx.doi.org/10.1097/MCO.0b013e32833a5107

Schakman O, Gilson H, Kalista S, Thissen JP. Mechanisms of muscle atrophy induced by glucocorticoids. Horm Res 2009;72 Suppl 1:36–41. http://dx.doi.org/10.1159/000229762

Rogliani P, Calzetta L, Cavalli F, Matera MG, Cazzola M. Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Pulm Pharmacol Ther 2016;40:95–103. http://dx.doi.org/10.1016/j.pupt.2016.07.009

Raghu G, Remy-Jardin M, Myers JL et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018;198(5):e44–68. http://dx.doi.org/10.1164/rccm.201807-1255ST

Barbosa-Silva MCG, Barros AJD. Indications and limitations of the use of subjective global assessment in clinical practice: an update. Curr Opin Clin Nutr Metab Care 2006;9(3):263–9. http://dx.doi.org/10.1097/01.mco.0000222109.53665.ed

Kozu R, Senjyu H, Jenkins SC, Mukae H, Sakamoto N, Kohno S. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration 2011;81(3):196–205. http://dx.doi.org/10.1159/000315475

Barcos VI, Enghelmayer JI. Nutrición en fibrosis pulmonar idiopática: ¿La gran olvidada? [Nutrition in idiopathic pulmonary fibrosis: The great forgotten?]. Medicina (B Aires) 2021;81(4):671-673.